NASDAQ NMS - GLOBAL MARKET · DTIL
-5.08% · -$0.4500 · Vol 232.8K
Market closed · last close 4:00 PM ET · price as of 16:10:42 ET
Precision BioSciences Inc

Precision BioSciences Inc

Biotechnology
$8.40
Card
Relationship Map

Veridion Score

BETAMEDIUM CONF · 5/6 factorsMethodology
Earnings absence reason unknown
DTIL
Precision BioSciences Inc
Mon Aug 24 · last completed session · Markets closed · resumes Tue 9:30 ET
BUY BIAS

Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.

65/ 100
Veridion Score
BUY BIAS · MEDIUM confidence
Sovereign · $25/mo
See why this score moved.
  • · Factor breakdown with raw signals
  • · Day-over-day delta + driver
  • · Factor coverage readout
  • · Valuation · hype · market flow
  • · Pro Chart event markers
  • · Score history + alerts
Start Sovereign · $25/mo →
Cancel anytime · or Reserve · $79/mo
Confidence: MEDIUM · 5/6 factors with data · Mon Aug 24 · last completed session · Markets closed · resumes Tue 9:30 ET
Share on X →
Veridion Score History · 90D
Loading score history
AI Analysis
Sovereign

Why is DTIL moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.
Loading DTIL catalysts
About Precision BioSciences Inc
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Listed since
2019
Employees
67
Country
US

Precision BioSciences Inc clinical stage gene editing company utilizing its proprietary ARCUS platform to concurrently develop two clinical-stage in vivo gene editing therapies. The ARCUS platform is used to develop in vivo gene editing therapies for sophisticated gene edits, including gene insertion (inserting DNA into gene to cause expression/add function), elimination (removing a genome, e.g. viral DNA), and excision (removing a large portion of a defective gene by delivering two ARCUS nucleases in a single adeno-associated virus ("AAV")).

Company website →
Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open
$8.82
Day high
$8.82
Day low
$8.36
Previous close
$8.85
52W high
$9.28
-9.48% from high
52W low
$3.57
85% of range
Market cap
$244.3M
EPS
$-5.9800
Beta
1.03
Shares out
27.6M
Volume
232.8K
0.78× rel vol
Avg volume
297.4K
VWAP
$8.59
Price history computed in-house
1W
+2.07%
1M
+15.23%
3M
+10.67%
1Y
+63.74%
YTD
+101.92%
SMA 50 $7.63 · above
SMA 200 $6.07 · above
52W position 85%

DTIL overview

Veridion Score
65
Registered · 2026-08-24
5 of 6 factors measured
Latest receipt rows
0
No recent disclosure on file.
13F holders
None on file

Related filings and maps

Relationship mapTrace receipt-backed holders and filings around DTIL.Congress trackerSearch the public STOCK Act disclosure ledger.MethodologyReview score inputs, coverage rules, and limitations.
Loading financial statements
Loading DTIL Form 4 filings
Public disclosures

Congress activity in DTIL

Congress trackerOpen ticker disclosure ledger →

No receipt-qualified Congressional disclosure is present for DTIL in the cached public ledger.

Federal contracts

DTIL contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for DTIL in this window.
Lobbying spend

DTIL lobbying filings, year to date.

Registered lobbying filings matched to Precision BioSciences Inc.

Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for DTIL in this window.
Loading news for DTIL
Analyst ratings
Sovereign unlock shows live analyst consensus for DTIL.
Options
Sovereign unlock shows live options positioning for DTIL.
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.